Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas S Rector

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Circulation. Heart Failure|July 1, 2011
Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trialInder S Anand, Thomas S Rector, John G Cleland, et al.
Journal of Cardiac Failure|September 5, 2014
Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trialRajendra K Premchand, Kamal Sharma, Sanjay Mittal, et al.
Infection Control and Hospital Epidemiology|May 9, 2013
Use of a computer decision support system and antimicrobial therapy appropriatenessGregory A Filice, Dimitri M Drekonja, Joseph R Thurn, et al.
Journal of Cardiac Failure|November 19, 2015
Extended Follow-Up of Patients With Heart Failure Receiving Autonomic Regulation Therapy in the ANTHEM-HF StudyRajendra K Premchand, Kamal Sharma, Sanjay Mittal, et al.
JACC. Heart Failure|April 1, 2017
Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT TrialInder S Anand, Brian Claggett, Jiankang Liu, et al.
Circulation. Heart Failure|August 14, 2012
Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trialCarolyn S P Lam, Peter E Carson, Inder S Anand, et al.
Circulation|August 17, 2005
Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFTInder S Anand, Michael A Kuskowski, Thomas S Rector, et al.
Journal of Cardiac Failure|June 19, 2016
Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection FractionParul U Gandhi, Sheryl L Chow, Thomas S Rector, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Circulation. Heart Failure|July 1, 2011
Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trialInder S Anand, Thomas S Rector, John G Cleland, et al.
Journal of Cardiac Failure|September 5, 2014
Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trialRajendra K Premchand, Kamal Sharma, Sanjay Mittal, et al.
Infection Control and Hospital Epidemiology|May 9, 2013
Use of a computer decision support system and antimicrobial therapy appropriatenessGregory A Filice, Dimitri M Drekonja, Joseph R Thurn, et al.
Journal of Cardiac Failure|November 19, 2015
Extended Follow-Up of Patients With Heart Failure Receiving Autonomic Regulation Therapy in the ANTHEM-HF StudyRajendra K Premchand, Kamal Sharma, Sanjay Mittal, et al.
JACC. Heart Failure|April 1, 2017
Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT TrialInder S Anand, Brian Claggett, Jiankang Liu, et al.
Circulation. Heart Failure|August 14, 2012
Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trialCarolyn S P Lam, Peter E Carson, Inder S Anand, et al.
Circulation|August 17, 2005
Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFTInder S Anand, Michael A Kuskowski, Thomas S Rector, et al.
Journal of Cardiac Failure|June 19, 2016
Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection FractionParul U Gandhi, Sheryl L Chow, Thomas S Rector, et al.
Pageof 7